197 related articles for article (PubMed ID: 32718257)
21. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK;
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828
[TBL] [Abstract][Full Text] [Related]
22. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry.
Bertomeu-Gonzalez V; Moreno-Arribas J; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Otero García D; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
Eur J Clin Invest; 2021 Apr; 51(4):e13431. PubMed ID: 33065765
[TBL] [Abstract][Full Text] [Related]
23. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome.
Batra G; Svennblad B; Held C; Jernberg T; Johanson P; Wallentin L; Oldgren J
Heart; 2016 Jun; 102(12):926-33. PubMed ID: 26928408
[TBL] [Abstract][Full Text] [Related]
24. Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands.
van Doorn S; Tavenier A; Rutten FH; Hoes AW; Moons KGM; Geersing GJ
BMJ Open; 2018 Aug; 8(8):e021681. PubMed ID: 30139900
[TBL] [Abstract][Full Text] [Related]
25. Blood hydrogen peroxide break-down activity in healthy subjects and in patients at risk of cardiovascular events.
Carnevale R; Nocella C; Pignatelli P; Bartimoccia S; Stefanini L; Basili S; Novo M; D'Amico A; Cammisotto V; Pastori D; Violi F
Atherosclerosis; 2018 Jul; 274():29-34. PubMed ID: 29747088
[TBL] [Abstract][Full Text] [Related]
26. Impact of Atrial Fibrillation on Outcome in Takotsubo Syndrome: Data From the International Takotsubo Registry.
El-Battrawy I; Cammann VL; Kato K; Szawan KA; Di Vece D; Rossi A; Wischnewsky M; Hermes-Laufer J; Gili S; Citro R; Bossone E; Neuhaus M; Franke J; Meder B; Jaguszewski M; Noutsias M; Knorr M; Heiner S; D'Ascenzo F; Dichtl W; Burgdorf C; Kherad B; Tschöpe C; Sarcon A; Shinbane J; Rajan L; Michels G; Pfister R; Cuneo A; Jacobshagen C; Karakas M; Koenig W; Pott A; Meyer P; David Arroja J; Banning A; Cuculi F; Kobza R; Fischer TA; Vasankari T; Airaksinen KEJ; Napp LC; Budnik M; Dworakowski R; MacCarthy P; Kaiser C; Osswald S; Galiuto L; Chan C; Bridgman P; Beug D; Delmas C; Lairez O; Gilyarova E; Shilova A; Gilyarov M; Kozel M; Tousek P; Winchester DE; Galuszka J; Ukena C; Poglajen G; Carrilho-Ferreira P; Hauck C; Paolini C; Bilato C; Kobayashi Y; Prasad A; Rihal CS; Liu K; Schulze PC; Bianco M; Jörg L; Rickli H; Pestana G; Nguyen TH; Böhm M; Maier LS; Pinto FJ; Widimský P; Felix SB; Opolski G; Braun-Dullaeus RC; Rottbauer W; Hasenfuß G; Pieske BM; Schunkert H; Thiele H; Bauersachs J; Katus HA; Horowitz JD; Di Mario C; Münzel T; Crea F; Bax JJ; Lüscher TF; Ruschitzka F; Duru F; Borggrefe M; Ghadri JR; Akin I; Templin C
J Am Heart Assoc; 2021 Aug; 10(15):e014059. PubMed ID: 34315238
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation.
Pastori D; Sciacqua A; Marcucci R; Farcomeni A; Perticone F; Del Ben M; Angelico F; Baratta F; Pignatelli P; Violi F;
Mayo Clin Proc; 2020 Mar; 95(3):513-520. PubMed ID: 31753536
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score.
Pastori D; Farcomeni A; Poli D; Antonucci E; Angelico F; Del Ben M; Cangemi R; Tanzilli G; Lip GY; Pignatelli P; Violi F
Intern Emerg Med; 2016 Mar; 11(2):199-204. PubMed ID: 26471883
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873
[TBL] [Abstract][Full Text] [Related]
30. Adverse clinical events in Japanese atrial fibrillation patients with and without coronary artery disease-findings from the SAKURA AF Registry.
Fukamachi D; Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Nishida T; Kojima T; Hanada S; Nomoto K; Sonoda K; Arima K; Kogawa R; Takahashi F; Kotani T; Ohkubo K; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
Curr Med Res Opin; 2019 Dec; 35(12):2053-2062. PubMed ID: 31355684
[No Abstract] [Full Text] [Related]
31. Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation.
Bassand JP; Virdone S; Goldhaber SZ; Camm AJ; Fitzmaurice DA; Fox KAA; Goto S; Haas S; Hacke W; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; van Eickels M; Verheugt FWA; Kakkar AK
Circulation; 2019 Feb; 139(6):787-798. PubMed ID: 30586740
[TBL] [Abstract][Full Text] [Related]
32. Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
Shih CJ; Ou SM; Chao PW; Kuo SC; Lee YJ; Yang CY; Tarng DC; Lin CC; Huang PH; Li SY; Chen YT
Circulation; 2016 Jan; 133(3):265-72. PubMed ID: 26680239
[TBL] [Abstract][Full Text] [Related]
33. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
Berg DD; Ruff CT; Jarolim P; Giugliano RP; Nordio F; Lanz HJ; Mercuri MF; Antman EM; Braunwald E; Morrow DA
Circulation; 2019 Feb; 139(6):760-771. PubMed ID: 30586727
[TBL] [Abstract][Full Text] [Related]
34. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry.
Dai Y; Yang J; Gao Z; Xu H; Sun Y; Wu Y; Gao X; Li W; Wang Y; Gao R; Yang Y;
BMC Cardiovasc Disord; 2017 Jan; 17(1):2. PubMed ID: 28052755
[TBL] [Abstract][Full Text] [Related]
35. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
[TBL] [Abstract][Full Text] [Related]
36. Atrial Fibrillation and Cardiovascular Outcomes in the Elderly.
O'Neal WT; Salahuddin T; Broughton ST; Soliman EZ
Pacing Clin Electrophysiol; 2016 Sep; 39(9):907-13. PubMed ID: 27333877
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of atrial fibrillation and cardiovascular risk factors in a 63-65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study.
Berge T; Lyngbakken MN; Ihle-Hansen H; Brynildsen J; Pervez MO; Aagaard EN; Vigen T; Kvisvik B; Christophersen IE; Steine K; Omland T; Smith P; Røsjø H; Tveit A
BMJ Open; 2018 Aug; 8(7):e021704. PubMed ID: 30068617
[TBL] [Abstract][Full Text] [Related]
38. Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation.
Koga M; Yoshimura S; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Todo K; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Yagita Y; Kario K; Shiozawa M; Sato S; Yamagami H; Arihiro S; Toyoda K;
Stroke; 2016 Oct; 47(10):2582-8. PubMed ID: 27531346
[TBL] [Abstract][Full Text] [Related]
39. Impact of Atrial Fibrillation During ST-Segment-Elevation Myocardial Infarction on Infarct Characteristics and Prognosis.
Reinstadler SJ; Stiermaier T; Eitel C; Fuernau G; Saad M; Pöss J; de Waha S; Mende M; Desch S; Metzler B; Thiele H; Eitel I
Circ Cardiovasc Imaging; 2018 Feb; 11(2):e006955. PubMed ID: 29391346
[TBL] [Abstract][Full Text] [Related]
40. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
